Neurologian yksikkö
Department of Neurology

Julkaisut 2008
Publications 2008

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Alafuzoff I et al. Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium.
2 Alafuzoff I et al. Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium.
3 Aho L et al. Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects.
4 Alafuzoff I. Cerebral amyloid angiopathy, hemorrhages and superficial siderosis.
5 Bell JE et al. Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.
6 Bertram L et al. No association between CALHM1 and Alzheimers's disease risk.
7 Blom ES et al. Low prevalence of APP duplications in Swedish and Finnish patients with early-onset Alzheimer's disease.
8 Elovaara I et al. Immunologinen lääkehoito MS-taudin eri vaiheissa.
9 Eskelinen MH et al. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study.
10 Goldstein LB et al. Relative effects of statin therapy on stroke and cardiovascular events in men and women. Secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study.
11 Hansson Petersen CA et al. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.
12 Helisalmi S et al. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.
13 Helisalmi S et al. Genetic study between SIRT1, PPARD, PGC-1alfa genes and Alzheimer's disease.
14 Herukka S-K et al. CSF Abeeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophy.
15 Hicks AU et al. Long-term assessment of enriched housing and subventricular zone derived cell transplantation after focal ischemia in rats.
16 Huhtiniemi T et al. Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.
17 Hämäläinen A et al. Apolipoprotein E epsilon4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study.
18 Hätinen S et al. Improved sensorimotor function by rolipram following focal cerebral ischemia in rats.
19 Immonen A et al. Kuka hyötyy epilepsiakirurgiasta?
20 Jauhiainen A. Functional and Structural Magnetic Resonance Imaging Studies in Mild Cognitive Impairment and Alzheimer's Disease.
21 Jauhiainen AM et al. Differential hypometabolism patterns according to mild cognitive impairment subtypes.
22 Jukarainen NM et al. Quantification of 1H NMR spectra of human cerebrospinal fluid: a protocol based on constrained total-line-shape analysis.
23 Julkunen P et al. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study.
24 Julkunen P et al. Mechanical characterization of articular cartilage by combining magnetic resonance imaging and finite-element analysis - a potential functional imaging technique.
25 Kalesnykas G et al. Neurodegeneration and cellular stress in the retina and optic nerve in rat cerebral ischemia and hypoperfusion models.
26 Kivipelto M et al. Apolipoprotein E epsilon4 magnifiles lifestyle risks for dementia: a population-based study.
27 Kiviranta PH et al. Characterization of the binding properties of SIRT2 inhibitors with a N-(3-phenylpropenoyl)-glycine tryptamide backbone.
28 Koivunen J et al. PET amyloid ligand (11C)PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment.
29 Korolainen MA et al. 3rd Annual Finnprot Meeting: from cells to systems. 3rd Annual Finnprot Meeting: from cells to systems. March 10-12 2008, Tahko, Nilsiä, Finland.
30 Kovacs GG et al. Mixed brain pathologies in dementia: the BrainNet Europe consortium experience.
31 Kuusisto E et al. Use of p62/SQSTM1 antibodies for neuropathological diagnosis.
32 Lane R et al. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
33 Lappalainen RS et al. The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats.
34 Leinonen V et al. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11- labeled Pittsburgh compound B.
35 Lämsä R et al. Genetic study evaluating LDLR polymorphisms and Alzheimer's disease.
36 Mäkinen S et al. Coaccumulation of calcium and b-amyloid in the thalamus after transient middle cerebral artery occlusion in rats.
37 O'Dushlaine CT et al. An assessment of the Irish population for large-scale genetic mapping studies involving epilepsy an other complex diseases.
38 Ojala JO et al. Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells.
39 Parkkinen L et al. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance.
40 Peurala SH et al. Restoration of normal cortical excitability and gait ability in acute stroke after intensive rehabilitation.
41 Pihlajamäki M, Sperling RA. fMRI: use in early Alzheimer's disease and in clinical trials.
42 Pikkarainen M et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry.
43 Pirttilä T. Lievä kognitiivinen heikentyminen -ennusteeltaan heterogeeninen oireyhtymä.
44 Ryhänen T et al. Radicicol but not geldanamycin evokes oxidative stress response and efflux protein inhibition in ARPE-19 human retinal pigment epithelial cells.
45 Salminen A et al. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging.
46 Salminen A et al. SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation?
47 Salminen A et al. Terpenoids: natural inhibitors of NF-kappaB signaling with anti-inflammatory and anticancer potential.
48 Salminen A et al. Interaction of aging-associated signaling cascades: Inhibition of NF-kappaB signaling by longevity factors FoxOs and SIRT1.
49 Salminen A et al. Amyloid-beta oligomers set fire to inflammasomes and induce Alzherimer's pathology.
50 Salminen A et al. Innate immunity meets with cellular stress at the IKK complex: Regulation of the IKK complex by HSP70 and HSP90.
51 Salminen A et al. NEMO shuttle: a link between DNA damage and NF-kappaB activation in progeroid syndromes?
52 Salminen A et al. ROCK, PAK, and Toll of synapses in Alzheimer's disease.
53 Sivenius J. TIA- ja aivoinfarktipotilaan antitromboottinen lääkehoito.
54 Soininen H, Hänninen T. Dementoivat sairaudet ja kognitiivinen prosessointi.
55 Suhonen J et al. Hyvät hoitokäytännöt etenevien muistisairauksien kaikissa vaiheissa.
56 Suomalaisen Lääkäriseuran Duodecimin ja et al. Aikuisten epilepsiat.
57 Suuronen T et al. Regulation of ERalfa signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90.
58 Tapiola T et al. MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow-up study.
59 Tarkka IM et al. Alterations in cortical excitability in chronic stroke after constraint-induced movement therapy.
60 The European Stroke Organisation (ESO), Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008.
61 Tiihonen J et al. Brain anatomy of persistent violent offenders: more rather than less.
62 Tukiainen T et al. A multi-metabolite analysis of serum by 1H NMR spectroscopy: Early systemic signs of Alzheimer's disease.
63 Vepsäläinen S et al. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.
64 Visser PJ et al. Development of screening guidelines and clinical criteria for predementia Alzheimer's disease.
65 Zhao CS et al. CNS-active drugs in aging population at high risk of cerebrovascular events: Evidence from preclinical and clinical studies.

Neurologian yksikkö Department of Neurology
Julkaisutietokanta 27.8.2009 Publications Data Base 27.8.2009